×
戻る Agenda
Session 9 Track 3: Evolving Regulatory Landscape for Oligonucleotide Control Strategy and Comparability
Session Chair(s)
Claus Rentel, PHD
Vice President, Analytical Development and Quality Control
Ionis Pharmaceuticals, Inc., United States
Session 9 Track 3: Evolving Regulatory Landscape for Oligonucleotide Control Strategy and Comparability